VANGUARD GROUP INC - PHIO PHARMACEUTICALS CORP ownership

PHIO PHARMACEUTICALS CORP's ticker is PHIO and the CUSIP is 71880W303. A total of 16 filers reported holding PHIO PHARMACEUTICALS CORP in Q1 2022. The put-call ratio across all filers is - and the average weighting 0.0%.

Quarter-by-quarter ownership
VANGUARD GROUP INC ownership history of PHIO PHARMACEUTICALS CORP
ValueSharesWeighting
Q4 2022$57,487
-54.0%
154,536
-29.2%
0.00%
Q3 2022$125,000
-40.5%
218,192
-26.8%
0.00%
Q2 2022$210,000
-21.9%
297,971
-2.0%
0.00%
Q1 2022$269,000
-5.6%
304,119
+6.8%
0.00%
Q4 2021$285,000
-50.7%
284,8770.0%0.00%
Q3 2021$578,000
-7.5%
284,877
+3.0%
0.00%
Q2 2021$625,000
+90.0%
276,561
+125.4%
0.00%
Q1 2021$329,000
+66.2%
122,697
+67.0%
0.00%
Q4 2020$198,00073,4900.00%
Other shareholders
PHIO PHARMACEUTICALS CORP shareholders Q1 2022
NameSharesValueWeighting ↓
WEDBUSH SECURITIES INC 33,374$73,0000.01%
UBS Group AG 11,159$24,0000.00%
BANK OF AMERICA CORP /DE/ 1$00.00%
WELLS FARGO & COMPANY/MN 18$00.00%
CONCOURSE FINANCIAL GROUP SECURITIES, INC. 0$00.00%
HSBC HOLDINGS PLC 11,512$25,0000.00%
BlackRock Inc. 19$00.00%
Valeo Financial Advisors, LLC 250$1,0000.00%
JPMORGAN CHASE & CO 200$00.00%
Renaissance Technologies 74,182$162,0000.00%
View complete list of PHIO PHARMACEUTICALS CORP shareholders